-
公开(公告)号:US20120258039A1
公开(公告)日:2012-10-11
申请号:US13367178
申请日:2012-02-06
申请人: Daniela Gast , Peter Altevogt , Gerhard Moldenhauer , Frank Brietling , Achim Krüger , Silke Wolterink , Sandra Lüttgau , Ulrich Mõbius , Yi Li
发明人: Daniela Gast , Peter Altevogt , Gerhard Moldenhauer , Frank Brietling , Achim Krüger , Silke Wolterink , Sandra Lüttgau , Ulrich Mõbius , Yi Li
IPC分类号: A61K39/395 , A61M37/00 , A61N5/10 , A61K51/10 , A61P35/00
CPC分类号: C07K16/2803 , A61K39/39558 , A61K45/06 , A61K2039/505 , A61N5/02 , A61N5/0613 , A61N5/10 , A61N2005/0661 , A61N2005/1087 , A61N2005/1089 , C07K2317/24 , C07K2317/41 , C07K2317/622 , C07K2317/73 , C07K2317/76 , C07K2317/92 , C07K2319/30 , G01N33/57492
摘要: The present invention relates to the anti-L1 monoclonal antibody 9.3 as well as to related antibodies or binding molecules and well as to the uses thereof, especially in tumor treatment.
摘要翻译: 本发明涉及抗L1单克隆抗体9.3以及相关抗体或结合分子,以及其用途,特别是在肿瘤治疗中。